Zobrazeno 1 - 10
of 281
pro vyhledávání: '"Kazuyoshi Sato"'
Autor:
Ryota Azuma, Kazuyoshi Sato, Hiroki Sunadoi, Yasushi Ishii, Utano Tomaru, Masatoshi Motohashi
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 18, Iss 1, Pp 1-6 (2023)
Abstract Background Primary cardiac myxofibrosarcoma is rare and commonly occurs in the left atrium. Myxofibrosarcoma is aggressive and has a high mortality rate due to its high rate of recurrence. Complete surgical resection is considered important;
Externí odkaz:
https://doaj.org/article/f90727e6650d4aae84165c1eea062115
Autor:
Masao Toyoda, Nobumichi Saito, Moritsugu Kimura, Nobuo Hatori, Kouichi Tamura, Masaaki Miyakawa, Kazuyoshi Sato, Akira Kanamori, Kazuo Kobayashi
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 9, Pp 1520-1527 (2022)
ABSTRACT Aims/Introduction We previously reported that sodium–glucose cotransporter 2 inhibitor (SGLT2i) treatment was associated with an improvement of the albumin‐to‐creatinine ratio in Japanese patients with type 2 diabetes mellitus and chro
Externí odkaz:
https://doaj.org/article/9d29947443064f66a7b0e820db4c0a8b
Autor:
Kazuo Kobayashi, Masao Toyoda, Nobuo Hatori, Hiroyuki Sakai, Takayuki Furuki, Kazuyoshi Sato, Yasuo Terauchi, Kouichi Tamura, Akira Kanamori
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract The cardiovascular and renal protective effects of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide 1 receptor agonists (GLP-1Ras) are enhanced by low/controlled blood pressure (BP). However, the BP-lowering eff
Externí odkaz:
https://doaj.org/article/bd70b55d1f1048e38e0f18e5f0592078
Autor:
Kazuo Kobayashi, Masao Toyoda, Nobuo Hatori, Takayuki Furuki, Hiroyuki Sakai, Yutaka Hatori, Kazuyoshi Sato, Masaaki Miyakawa, Kouichi Tamura, Akira Kanamori
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 4, Pp 1050-1062 (2022)
Abstract Polypharmacy is a serious concern in general practice, especially among elder patients; however, the evidence showing significantly poor renal outcomes is not sufficient. This survey was performed to evaluate the effect of polypharmacy on th
Externí odkaz:
https://doaj.org/article/af00ef77ab7d403da246c319e3383ad7
Publikováno v:
Alexandria Engineering Journal, Vol 61, Iss 4, Pp 3105-3124 (2022)
Catalytic hydrotreating of fatty acid is respected to produce bio-based chemicals especially oleochemicals that can be applied as a high valuable raw material or intermediate materials for industries. Low-cost Ni/LY char and limonite catalysts can co
Externí odkaz:
https://doaj.org/article/98366ceb305a487692e72e6fd7f4e988
Autor:
Kazuo Kobayashi, Masao Toyoda, Nobuo Hatori, Takayuki Furuki, Hiroyuki Sakai, Kazuyoshi Sato, Masaaki Miyakawa, Kouichi Tamura, Akira Kanamori
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 8, Pp 1408-1416 (2021)
Abstract Aims/Introduction Large‐scale clinical trials have reported that, in patients with type 2 diabetes mellitus, sodium–glucose cotransporter 2 (SGLT2) inhibitor treatment affords favorable renal outcomes; the underlying mechanisms, however,
Externí odkaz:
https://doaj.org/article/336ae2edd3f9447380440ee6088616c4
Autor:
Kazuyoshi Sato, Tomoko Yago
Publikováno v:
Journal of ELT Research (2022)
Although the Japanese government decided to make English a formal subject for fifth and sixth graders from 2020, there has been little discussion about how to prepare English teachers. In fact, Curtain and Dahlberg (2003) pointed out that lack of ski
Externí odkaz:
https://doaj.org/article/fce73d280eff4db3b01f431b136cbf9e
Autor:
Kazuo Kobayashi, Masao Toyoda, Moritsugu Kimura, Nobuo Hatori, Takayuki Furuki, Hiroyuki Sakai, Masahiro Takihata, Tomoya Umezono, Shun Ito, Daisuke Suzuki, Hiroshi Takeda, Akira Kanamori, Hisakazu Degawa, Hareaki Yamamoto, Hideo Machimura, Atsuko Mokubo, Keiichi Chin, Mitsuo Obana, Toshimasa Hishiki, Kouta Aoyama, Shinichi Nakajima, Shinichi Umezawa, Hidetoshi Shimura, Togo Aoyama, Kazuyoshi Sato, Masaaki Miyakawa
Publikováno v:
Clinical and Experimental Hypertension, Vol 41, Iss 7, Pp 637-644 (2019)
Decrease in blood pressure contributes to the reno-protective effects of sodium-glucose cotransporter 2 inhibitors; however, its relationship with home monitoring of blood pressure is unclear. We retrospectively analyzed 101 visiting members of the K
Externí odkaz:
https://doaj.org/article/b1b31d2ac3f746d1be93392f3402d38a
Autor:
Kazuo Kobayashi, Masao Toyoda, Nobuo Hatori, Kazuyoshi Sato, Masaaki Miyakawa, Kouichi Tamura, Akira Kanamori
Publikováno v:
Journal of Diabetes Research, Vol 2021 (2021)
Background and Aim. Strong evidence exists supporting the utility of sodium glucose cotransporter inhibitors (SGLT2is) for treating not only cardiovascular events but also renal events. We previously reported that SGLT2is improved the urine albumin-t
Externí odkaz:
https://doaj.org/article/ddf57f8eac3841b68398baa03236bead
Publikováno v:
Clinical and Experimental Hypertension, Vol 39, Iss 8, Pp 705-710 (2017)
To evaluate the Japanese Society of Hypertension Guidelines for the Management of Hypertension 2014 (JSH2014) among Japanese general practitioners (GPs), we used a questionnaire survey with 209 GPs from the Kanagawa Physicians Society. Overall, 93.6%
Externí odkaz:
https://doaj.org/article/38711e3f040b4b9db0e57160f13c5659